发明名称 |
PHARMACEUTICAL FORMULATION FOR SUBCUTANEOUS, INTRAMUSCULAR OR INTRADERMAL ADMINISTRATION OF FACTOR VIII OR FACTOR IX |
摘要 |
The present invention relates to a pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration comprising coagulation factor VIII or factor IX and use thereof for manufacture of a medicament for treating haemophilia A or B. The formulation comprises coagulation factor VIII or factor IX with an activity of at least 200 IU/ml and an additive increasing the bio-availability of factor VIII or factor IX. Tests with factor VIII gives a therapeutic level of active factor VIII in the blood stream for a surprisingly long period of time after subcutaneous, intramuscular or intradermal administration. The factor VIII is suitably a highly purified recombinant factor VIII, and preferably a deletion derivative thereof, which can be used for the manufacture of a medicament for subcutaneous administration.
|
申请公布号 |
WO9526750(A1) |
申请公布日期 |
1995.10.12 |
申请号 |
WO1995SE00348 |
申请日期 |
1995.03.31 |
申请人 |
PHARMACIA AB;SPIRA, JACK;WIDLUND, LARS;OESTERBERG, THOMAS;SJOESTROEM, BRITA;MIKAELSSON, MARIANNE |
发明人 |
SPIRA, JACK;WIDLUND, LARS;OESTERBERG, THOMAS;SJOESTROEM, BRITA;MIKAELSSON, MARIANNE |
分类号 |
A61K9/08;A61K9/107;A61K38/17;A61K38/37;A61K38/43;A61K38/48;A61K47/36;A61K47/42;A61K47/44;A61P7/04;(IPC1-7):A61K38/37;A61K38/36;A61K35/16 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|